GILEAD SCIENCES CHALLENGES THE GRANT BY THE RUSSIAN GOVERNMENT OF THE RIGHT TO USE WITHOUT CONSENT ITS PATENTS FOR MEDICINES EMPLOYED IN THE COVID- 19 THERAPY

marketude Alisa Pestryakova, Coronavirus, Intellectual Property, Pharmaceuticals and Life Sciences, Publications, Russia, Russia Express

In January 2021 it became public that the Russian Government had granted right to use 5 patents owned by Gilead Sciences, Inc. in relation to medicines employed in the therapy of COVID-19 without the consent of the patent holder…

Download Article